Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8365-66
|
pubmed:dateCreated |
1984-2-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1499
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6140587-Abnormalities, Drug-Induced,
pubmed-meshheading:6140587-Epilepsy,
pubmed-meshheading:6140587-Female,
pubmed-meshheading:6140587-Humans,
pubmed-meshheading:6140587-Maternal-Fetal Exchange,
pubmed-meshheading:6140587-Pregnancy,
pubmed-meshheading:6140587-Pregnancy Complications,
pubmed-meshheading:6140587-Valproic Acid
|
pubmed:articleTitle |
Maternal epilepsy, valproate exposure, and birth defects.
|
pubmed:publicationType |
Letter
|